Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Chronic Pain, Emotions and Professional Football

6 mai 2026 mis à jour par: Evidence In Motion
Chronic pain is influenced by biological, psychological, and social factors, including emotions and environmental context. Prior research demonstrates that emotional states and psychosocial processes such as depression, fear-avoidance, and catastrophizing significantly shape the pain experience. Professional sports fandom is known to influence emotional well-being, but its relationship to chronic pain has not yet been examined. This longitudinal observational study aims to evaluate whether weekly performance outcomes of participants' favorite U.S. professional football (NFL) teams are associated with fluctuations in self-reported pain intensity, depression, and pain catastrophization among adults with chronic pain who identify as avid football fans. Participants will complete weekly online surveys throughout the NFL regular season, reporting pain ratings (NPRS) and depressive symptoms (PHQ-2). Team performance (win/loss, played/did not play, rival results) will be recorded by the research team. The study seeks to determine whether sports-related emotional fluctuations correlate with changes in chronic pain experiences.

Aperçu de l'étude

Description détaillée

Chronic pain is now widely recognized as a complex biopsychosocial condition rather than a purely physical phenomenon. The International Association for the Study of Pain (IASP) defines pain as an "unpleasant sensory and emotional experience," and neuroimaging studies reveal that chronic pain involves shifting brain activation from nociceptive to cognitive and emotional circuits over time. This evolving understanding underscores the role of emotions, cognitions, and psychosocial factors in shaping the pain experience and contributes to the clinical difficulty of managing chronic pain.

Psychological factors-including fear-avoidance, catastrophizing, and depression-are known to strongly influence pain severity and disability. While these constructs are often tied to biomedical explanations (e.g., structural imaging findings), such explanations may increase fear or negative expectations and do not fully account for pain severity in many individuals. Social factors also interact with psychological processes to shape pain experiences, yet they remain understudied. One such social factor may be the emotional impact of a chronic pain sufferer's favorite sports team performance.

Sports fandom research demonstrates that strong fan identification provides psychological benefits such as belonging, self-esteem, and life satisfaction. Neuroimaging evidence suggests that sports-related wins activate reward networks, while losses trigger introspective and negative emotional states. Despite these findings, the potential link between weekly sports team performance and symptom fluctuations in people living with chronic pain has not been directly investigated.

This longitudinal observational study will examine whether weekly changes in the performance of participants' preferred NFL football team correlate with changes in self-reported chronic pain intensity (Numeric Pain Rating Scale), depressive symptoms (PHQ-2), and pain catastrophization (Pain Catastrophizing Scale). Participants will be adults aged 18 or older with chronic pain lasting more than one year and who meet predefined criteria for being avid fans of a current NFL team.

Following informed consent, participants will complete baseline demographic and clinical questionnaires. Each week throughout the NFL regular season, participants will receive a brief online survey assessing their pain and depressive symptoms. Independent of participant responses, the research team will document whether the participant's team played, whether they won or lost, and the performance of the team's primary rival.

Data will be analyzed descriptively and through inferential statistics to determine whether emotional changes associated with team performance are associated with clinically meaningful weekly changes in pain, depression, or catastrophizing. This study aims to generate preliminary evidence regarding the interaction between sports-related emotional experiences and chronic pain, potentially identifying a novel social component relevant to understanding pain variability.

Type d'étude

Observationnel

Inscription (Réel)

32

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Iowa
      • Story City, Iowa, États-Unis, 50248
        • Evidence in Motion

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte
  • Adulte plus âgé

Accepte les volontaires sains

Non

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

The study will include self-identified adults aged 18 and above who have experienced chronic pain (>1 year) and meet the criteria for avid professional football fans.

La description

Inclusion Criteria:

  • Age 18 and above
  • Chronic pain > 1 year
  • Provide written consent
  • Proficient in reading and understanding English
  • Identify as an avid football fan of a current US professional football team (NFL). Criteria include:
  • Watching all/most of their team's games during the season
  • Watching games of their main competitor
  • Engage in social media regarding their team during and outside of the season
  • Wears team apparel during and outside of the season

Exclusion Criteria:

  • Not willing to participate in the study
  • Not willing to comply with weekly data collection requirements
  • Do not meet the criteria for being classified as an avid football fan.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
Cohort 1: Avid NFL Fans with Chronic Pain

Participants in this cohort are adults aged 18 or older who have experienced chronic pain for more than one year and meet predefined criteria for being avid fans of an active U.S. professional football (NFL) team. All participants will complete baseline demographic and clinical questionnaires and will provide weekly self-reported measures of pain intensity (NPRS) and depressive symptoms (PHQ-2) throughout the NFL regular season. Team performance variables (game played, win/loss outcome, rival results) will be collected by the research team.

Study Activities:

Baseline demographic and football-related fan profile questionnaire Baseline Pain Catastrophizing Scale (PCS) Weekly NPRS and PHQ-2 surveys End-of-season PCS Research team documentation of weekly team performance and rival performance

Purpose:

To evaluate whether weekly NFL team performance is associated with fluctuations in pain intensity, depressive symptoms, and catastrophizing in individuals living with chronic pain

Aucune intervention : cohorte observationnelle

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Pain Intensity (Numeric Pain Rating Scale - NPRS)
Délai: Weekly assessments from study enrollment through the end of the NFL regular season (approximately September 2025 to January 2026).
Self-reported musculoskeletal pain intensity will be measured using the 0-10 Numeric Pain Rating Scale (NPRS), where 0 indicates "no pain" and 10 indicates "worst pain imaginable." Participants will report their average pain over the past week.
Weekly assessments from study enrollment through the end of the NFL regular season (approximately September 2025 to January 2026).
Depressive Symptoms (Patient Health Questionnaire-2 - PHQ-2)
Délai: Weekly assessments from study enrollment through the end of the NFL regular season (approximately September 2025 to January 2026).
Depressive symptoms will be measured using the 2-item PHQ-2, assessing anhedonia and depressed mood. Each item is rated 0 (not at all) to 3 (nearly every day), generating a score from 0-6.
Weekly assessments from study enrollment through the end of the NFL regular season (approximately September 2025 to January 2026).

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Pain Catastrophizing (Pain Catastrophizing Scale - PCS)
Délai: Weekly assessments from study enrollment through the end of the NFL regular season (approximately September 2025 to January 2026).
The PCS is a 13-item questionnaire assessing rumination, magnification, and helplessness related to pain. Each item is rated 0-4, with total scores ranging from 0-52. Higher scores indicate greater catastrophizing.
Weekly assessments from study enrollment through the end of the NFL regular season (approximately September 2025 to January 2026).
Correlation Between Weekly Team Performance and Symptom Changes
Délai: Weekly assessments from study enrollment through the end of the NFL regular season (approximately September 2025 to January 2026).

Team performance will be operationalized as:

Win, Loss, or Did Not Play,

Rival team win/loss,

Margin of victory/defeat. These variables will be analyzed against weekly NPRS and PHQ-2 scores to determine associations between sports-related emotional events and chronic pain symptoms.

Weekly assessments from study enrollment through the end of the NFL regular season (approximately September 2025 to January 2026).
Weekly Response Rate / Completion Rate
Délai: Weekly assessments from study enrollment through the end of the NFL regular season (approximately September 2025 to January 2026).
Proportion of participants completing each weekly survey.
Weekly assessments from study enrollment through the end of the NFL regular season (approximately September 2025 to January 2026).

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Collaborateurs

Les enquêteurs

  • Chercheur principal: Adriaan Louw, PT, PhD, Evidence in Motion

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

18 juillet 2025

Achèvement primaire (Réel)

9 janvier 2026

Achèvement de l'étude (Réel)

9 janvier 2026

Dates d'inscription aux études

Première soumission

11 mars 2026

Première soumission répondant aux critères de contrôle qualité

6 mai 2026

Première publication (Réel)

13 mai 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

13 mai 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

6 mai 2026

Dernière vérification

1 mai 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner